Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer’s disease with real-world clinical validation
Yan C, Grabowska M, Dickson A, Li B, Wen Z, Roden D, Michael Stein C, Embí P, Peterson J, Feng Q, Malin B, Wei W. Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer’s disease with real-world clinical validation. Npj Digital Medicine 2024, 7: 46. PMID: 38409350, PMCID: PMC10897392, DOI: 10.1038/s41746-024-01038-3.Peer-Reviewed Original ResearchGenerative artificial intelligenceDrug repurposing candidatesAlzheimer's diseaseRepurposing candidatesSearch spaceGenerative AIArtificial intelligenceChatGPTAD riskClinical datasetsAssociated with lower AD riskLower AD riskDrug repurposingDrug developmentAlzheimerTreatment of diseasesTechnologyDatasetIntelligence